Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
株式のランク #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
株価
$0.2219522
最終同期: 2025-09-11
時価総額
$1.10B
変化(1日)
0.04%
変化(1年)
0.17%
CN
取引 Hubei Biocause Pharmaceutical Co., Ltd. (000627)

カテゴリー

Hubei Biocause Pharmaceutical Co., Ltd.(000627)の配当利回りの履歴
Hubei Biocause Pharmaceutical Co., Ltd.(銘柄コード: 000627)の配当利回り(TTM)は2022-12-31時点で0.16%です。
過去5年間の平均配当利回り: 1.36%
Hubei Biocause Pharmaceutical Co., Ltd.(000627)の2000から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
2026 (TTM) 0.00% -100.00%
2023 3.86% 2,312.50%
2022 0.16% -46.67%
2021 0.30% -85.37%
2020 2.05% 376.74%
2019 0.43% -61.95%
2018 1.13% 175.61%
2017 0.41% 7.89%
2016 0.38% 123.53%
2015 0.17% -65.31%
2014 0.49% -43.02%
2013 0.86% 10.26%
2012 0.78% 39.29%
2011 0.56% 1.82%
2010 0.55% 41.03%
2009 0.39% -84.77%
2008 2.56% 814.29%
2007 0.28% -63.16%
2006 0.76% -70.77%
2005 2.60% 124.14%
2004 1.16% 18.37%
2003 0.98% 180.00%
2002 0.35% -55.70%
2001 0.79% 31.67%
2000 0.60% 0.00%
類似企業または競合他社の配当利回り(TTM)